IRIS
CIURLEO, ROSELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.890
EU - Europa 2.964
AS - Asia 1.497
SA - Sud America 491
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 11.883
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.835
RU - Federazione Russa 1.664
SG - Singapore 580
CN - Cina 455
BR - Brasile 408
SE - Svezia 338
IE - Irlanda 329
HK - Hong Kong 173
DE - Germania 126
IT - Italia 122
VN - Vietnam 111
UA - Ucraina 106
FR - Francia 78
FI - Finlandia 63
GB - Regno Unito 54
IN - India 43
CA - Canada 28
AR - Argentina 26
BD - Bangladesh 25
MX - Messico 20
AT - Austria 16
PL - Polonia 15
TR - Turchia 15
CO - Colombia 14
NL - Olanda 14
IQ - Iraq 13
JP - Giappone 12
VE - Venezuela 11
BE - Belgio 9
EC - Ecuador 9
MA - Marocco 8
PK - Pakistan 8
PY - Paraguay 8
ZA - Sudafrica 8
UY - Uruguay 7
UZ - Uzbekistan 7
JO - Giordania 6
TN - Tunisia 6
ID - Indonesia 5
IL - Israele 5
CI - Costa d'Avorio 4
ES - Italia 4
KE - Kenya 4
OM - Oman 4
PE - Perù 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
JM - Giamaica 3
KR - Corea 3
NP - Nepal 3
PH - Filippine 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
LT - Lituania 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
VC - Saint Vincent e Grenadine 1
Totale 11.883
Salva come PNG Salva come JPEG
Città #
Dallas 4.699
Moscow 469
Ashburn 399
Dublin 329
Chandler 315
Singapore 280
Nyköping 222
Jacksonville 193
Hong Kong 171
Beijing 140
Dearborn 87
San Jose 71
The Dalles 67
New York 61
Princeton 56
Lauterbourg 54
Dong Ket 52
Medford 49
Los Angeles 48
Cambridge 46
Boardman 43
Des Moines 43
Messina 33
Munich 31
Buffalo 27
Jinan 23
São Paulo 23
Ho Chi Minh City 20
Ann Arbor 18
Nanjing 18
Redondo Beach 18
Hebei 17
Rio de Janeiro 15
Tianjin 15
Guangzhou 14
Chennai 13
Vienna 13
Frankfurt am Main 12
Milan 12
Orem 12
Tokyo 12
Warsaw 12
Wilmington 12
Woodbridge 12
Bremen 11
Belo Horizonte 10
Santa Clara 10
Taiyuan 10
Turku 10
Brussels 9
Curitiba 9
Hanoi 9
Brooklyn 8
Catania 8
Hyderabad 8
London 8
Taizhou 8
Boston 7
Campinas 7
Columbus 7
Lancaster 7
Montreal 7
Seattle 7
Shanghai 7
Tashkent 7
Toronto 7
Washington 7
Amsterdam 6
Asunción 6
Brasília 6
Changsha 6
Chicago 6
Montevideo 6
Montréal 6
Salvador 6
Shenyang 6
Shenzhen 6
Stockholm 6
Amman 5
Baghdad 5
Contagem 5
Dhaka 5
Helsinki 5
Houston 5
Johannesburg 5
Joinville 5
Nanchang 5
Piracicaba 5
Poplar 5
Abidjan 4
Atlanta 4
City of London 4
Council Bluffs 4
Da Nang 4
Denver 4
Fuzhou 4
Haikou 4
Hefei 4
Istanbul 4
Lappeenranta 4
Totale 8.629
Salva come PNG Salva come JPEG
Nome #
(1)H-MR Spectroscopy in Traumatic Brain Injury. 4.780
1H Magnetic Resonance Spectroscopy of the brain: methods for absolute quantification of metabolites 208
Diffusion - weighted imaging and fluid-attenuated inversion recovery sequence in sporadic Creutzfeldt-Jakob disease. One - case report. 202
2/4-Substituted-9-fluorenones and their O-glucosides as potential immunomodulators and anti-herpes simplex virus-2 agents.Part 5 199
Automatic Algorithm for Segmentation of Atherosclerotic Carotid Plaque 186
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases 185
2-Phenylimino-5-arylidene-4-thiazolidinones. Synthesis and pharmacological evaluation on IL-1induced alteration in cartilage metabolism. 181
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. 181
5-ariliden-2,4-tiazolidindioni e 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori della PTP1B. 174
5-arylidene-2-phenylimino-4-thiazolidinones as PTP1B and LMW-PTP inhibitors 169
Functional evaluation of awareness in vegetative and minimally conscious state 167
Effects of diffusion signal modeling and segmentation approaches on subthalamic nucleus parcellation 165
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy. 165
Evaluation of in vitro aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones. 156
Functional neuroimaging in differential diagnosis and outcome assessment of patients with disorders of consciousness 154
In vivo probabilistic atlas of white matter tracts of the human subthalamic area combining track density imaging and optimized diffusion tractography 149
Functional connectivity in vegetative state patients 146
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia 145
Neurophysiological approach in comatose patients 138
Ventral intermediate nucleus structural connectivity-derived segmentation: anatomical reliability and variability 138
White matter substrates of functional connectivity dynamics in the human brain 137
In Vivo Super-Resolution Track-Density Imaging for Thalamic Nuclei Identification 137
5-Arylidene-2-phenylimino-4-thiazolidinones as protein tyrosine phosphatases inhibitors 137
ROLE OF MAGNETIC RESONANCE SPECTROSCOPIC IN THE METABOLIC CHANGES IN DE NOVO PARKINSON’S DISEASE AFTER DOPAMINERGIC THERAPY 133
The role of sativex in robotic rehabilitation in individuals with multiple sclerosis rationale, study design, and methodology 129
PROGETTAZIONE E SINTESI DI NUOVI INIBITORI DELL'ALDOSO REDUTTASI 123
Evaluation of olfactory dysfunction in neurodegenerative diseases. 123
Evaluation of olfactory dysfunction in neurodegenerative diseases 123
Synthesis and in vitro evaluation of 5-arylidene-3-hydroxyalkyl-2-phenylimino-4-thiazolidinones with antidegenerative activity on human chondrocyte cultures 121
The role of brain oscillations in post-stroke motor recovery: an overview 118
Reality orientation therapy (ROT) in Alzheimer’s disease. 112
Structure-based optimization of benzoic acids active as protein tyrosine phosphatase 1B and low molecular weight protein tyrosine phosphatase inhibitors 108
Propranolol for familial cerebral cavernous malformation (Treat_CCM): Study protocol for a randomized controlled pilot trial 103
Uso di glicosilidrolasi nella sintesi di 9-fluorenglicosidi potenziali agenti anti-HSV2 ed immunomodulatori 102
Sintesi, attività e molecular modelling di 5-ariliden-2,4-tiazolidindioni inibitori della PTP1B. 99
Striatal topographical organization: Bridging the gap between molecules, connectivity and behavior 98
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives 97
Neurogenic ejaculatory disorders: focus on current and future treatments. 97
Transcriptomic data analysis reveals a down-expression of galectin-8 in schizophrenia hippocampus 97
RUOLO DELLA RISONANZA MAGNETICA SPETTROSCOPICA NELLO STUDIO DELLE ALTERAZIONI METABOLICHE NELLA MALATTIA DI PARKINSON IN SEGUITO A TERAPIA DOPAMINERGICA 96
Neurorehabilitation as a multidisciplinary approach: amyotrophic lateral sclerosis 94
Role of Resveratrol and its Analogues in the Treatment of Neurodegenerative Diseases: Focus on Recent Discoveries 91
Nuovi inibitori competitivi non fosforilati delle fosfotirosina protein fosfatasi. 90
“2,4-Thiazolidinedione derivatives as potential agents for the treatment of type 2 diabetes and its chronic complications” 87
ROLE OF RESVERATROL AND ITS ANALOGUES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES: FOCUS ON RECENT DISCOVERIES, 87
The clinical use of quality of life scales in the neurodegenerative diseases 86
Sintesi e valutazione in vitro di 5-ariliden-2-fenilimino-4-tiazolidinoni inibitori di protein tirosina fosfatasi 85
Nuovi 5-ariliden-2,4-tiazolidindioni inibitori dell'aldoso reduttasi 82
Post-traumatic olfactory loss: Psychophysical, electrophysiological and neuroradiological findings in three single case studies 82
Nuovi 5-ariliden-2,4-tiazolidindioni non carbossilici inibitori dell'aldoso reduttasi 81
Olfactory event-related potentials in a functionally anosmic patient with arrested hydrocephalus 81
Persistent anosmia in a traumatic brain injury patient: role of orbitofrontal cortex. 80
Titolo: Ruolo della risonanza magnetica spettroscopica nello studio delle alterazioni metaboliche nella malattia di Parkinson in seguito a terapia dopaminergica 78
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study 73
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 73
Pharmacotherapy for disorders of consciousness: are 'awakening' drugs really a possibility? 68
Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson’s Disease? 67
Role of statins in the treatment of multiple sclerosis 67
Identification of common pathogenetic processes between schizophrenia and diabetes mellitus by systems biology analysis 65
Role of diffusion tensor imaging in the diagnosis and management of post-traumatic anosmia 39
null 37
Neuroanatomical correlates of peripersonal space: bridging the gap between perception, action, emotion and social cognition 33
Transcriptomic Data Analysis Reveals a Down-Expression of Galectin-8 in Schizophrenia Hippocampus 28
Totale 11.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 32 21 66
2021/2022334 2 24 7 8 31 1 55 6 8 15 48 129
2022/20231.122 95 114 44 97 92 124 27 56 425 8 28 12
2023/2024312 21 45 22 35 30 96 1 20 2 14 6 20
2024/20251.204 7 15 38 67 46 24 31 265 331 86 90 204
2025/20268.025 142 1.505 3.402 334 334 834 371 486 473 144 0 0
Totale 11.932